AFC-HD AMS Life Science Co., Ltd. announces an Equity Buyback for 300,000 shares, representing 2.11% for ¥300 million.
October 26, 2021 at 10:40 pm
Share
AFC-HD AMS Life Science Co., Ltd. (JASDAQ:2927) announces an share repurchase program. Under the program the company will repurchase 300,000 shares, representing 2.11% of the outstanding shares, for ¥300 million. The purpose of the program is to enhance capital efficiency and improve shareholder returns. The program will expire on December 30, 2021. As of October 27, 2021, the company had 14,387,699 shares in issue and 196,594 shares in treasury.
AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.
AFC-HD AMS LIFE SCIENCE CO., LTD. 
